SYNAERION
DEAD

Serial Number

90624333

Owner

Synaerion Therapeutics, Inc.

Attorney

Sherry Flax

Filing Date

Apr 5, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SYNAERION Trademark

Serial Number: 90624333

SYNAERION is a trademark filed by Synaerion Therapeutics, Inc. on April 5, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Synaerion Therapeutics, Inc. (3 trademarks)

538 Newtown Road
Berwyn, PA 19312

Entity Type: 03

Trademark Details

Filing Date

April 5, 2021

Registration Date

Not Registered

Published for Opposition

December 28, 2021

Goods & Services

Biological preparations for the treatment of central nervous system disorders and cancer; Pharmaceutical preparations for the treatment of central nervous system disorders and cancer

Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical laboratory services; Pharmaceutical products development; Pharmaceutical research and development; Research and development in the field of central nervous system and oncology disorders; Scientific and technological services, namely, scientific research, analysis, development, testing, and providing clinical trials in the field of pharmaceuticals for the diagnosis and treatment of central nervous system disorders and oncology disorders

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 26, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 26, 2022 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 22, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 28, 2021 NPUB
PUBLISHED FOR OPPOSITION
Dec 28, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 8, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2021 CNSA
ASSIGNED TO EXAMINER
Nov 18, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 12, 2021 NWOS
NEW APPLICATION ENTERED
Apr 8, 2021 NWAP